Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Raised by Ameriprise Financial Inc.

Ameriprise Financial Inc. increased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 191.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after acquiring an additional 99,819 shares during the period. Ameriprise Financial Inc. owned about 2.80% of Mesa Laboratories worth $20,026,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Franklin Resources Inc. raised its stake in shares of Mesa Laboratories by 27.8% during the 3rd quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier’s stock worth $828,000 after purchasing an additional 1,403 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Mesa Laboratories by 29.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 8,406 shares of the medical instruments supplier’s stock worth $1,092,000 after purchasing an additional 1,906 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of Mesa Laboratories by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after purchasing an additional 73 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in shares of Mesa Laboratories by 8.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier’s stock worth $75,566,000 after purchasing an additional 43,927 shares in the last quarter. Finally, Sei Investments Co. raised its stake in shares of Mesa Laboratories by 246.2% during the 4th quarter. Sei Investments Co. now owns 5,411 shares of the medical instruments supplier’s stock worth $714,000 after purchasing an additional 3,848 shares in the last quarter. 90.60% of the stock is owned by hedge funds and other institutional investors.

Mesa Laboratories Stock Up 1.0%

MLAB opened at $121.35 on Friday. Mesa Laboratories, Inc. has a fifty-two week low of $83.68 and a fifty-two week high of $155.12. The business has a 50-day moving average of $118.37 and a 200-day moving average of $126.59. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.71 and a quick ratio of 0.53. The company has a market capitalization of $659.42 million, a PE ratio of -2.62 and a beta of 0.97.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories’s payout ratio is -1.38%.

Insider Activity at Mesa Laboratories

In related news, CEO Gary M. Owens sold 21,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the transaction, the chief executive officer now directly owns 43,337 shares of the company’s stock, valued at approximately $5,369,887.67. This trade represents a 32.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 4.40% of the stock is owned by company insiders.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.